|
Mr. Podlesak is the Chief Executive Officer of Cerexa. Cerexa was spun out of Peninsula Pharmaceuticals where Mr. Podlesak was also the Chief Executive Officer and where he led the sale of Peninsula to Johnson & Johnson. Mr. Podlesak has over 20 years of strategic operational and commercial experience within the pharmaceutical industry. Prior to Peninsula Mr. Podlesak served as Senior Vice President and Head of a North American Business Unit for Novartis AG and as a member of Novartis’ Pharmaceutical Executive Committee and Global Leadership Team. Earlier in his career Mr. Podlesak served as Vice President and Head of the CEC division of Allergan Inc. and as member of Allergan’s North American and Global Management Team. Mr. Podlesak spent the first ten years of his career with SmithKline Beecham (now GlaxoSmithKline plc) where he was promoted to eight positions of increasing responsibility during his tenure with the company. Mr. Podlesak serves on the Board of Directors of two publicly traded pharmaceutical companies Avanir Pharmaceuticals and DOV Pharmaceuticals and is a member of the board of directors of Prevent Blindness a non profit organization that focuses on preventable blindness with a particular emphasis on children. Mr. Podlesak holds a B.A. in Business Administration and an M.B.A. from Pepperdine University. | 